Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-14-002051
Filing Date
2014-12-22
Accepted
2014-12-22 17:05:36
Documents
2
Period of Report
2014-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K oncolyticsform6k.htm 6-K 15784
2 NEWS RELEASE DATED DECEMBER 22, 2014 ex991.htm EX-99.1 7296
  Complete submission text file 0001279569-14-002051.txt   24092
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 141303713
SIC: 2834 Pharmaceutical Preparations